Xinganmo has recently unveiled a significant upgrade to its AI-driven protein optimization and design platform, MoleculeOS. Leveraging the robust capabilities of the NewOrigin (Darwin) large model, the platform now excels in ultra-high-precision dynamic simulation and design of macromolecules. It has achieved industrial-level accuracy in critical tasks, including the structural prediction of antibody-antigen complexes and protein-small molecule interactions. This breakthrough addresses key industry challenges that even prominent models like AlphaFold 3 have struggled to resolve, particularly in predicting and designing protein dynamic structures. To date, MoleculeOS has proven its industrial utility in the real-world pipelines of numerous leading pharmaceutical and synthetic biology companies, delivering remarkable outcomes such as a fivefold increase in strain yield and over a 400-fold surge in drug expression levels.